Pandox AB (publ)
SSE:PNDX-B.ST
153.7 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 6,880 | 5,654 | 3,273 | 3,178 | 5,553 | 5,124 | 4,269 | 3,945 | 3,589 | 3,075.6 | 2,896.8 | 2,774.4 |
Cost of Revenue
| 3,262 | 2,550 | 1,546 | 1,563 | 2,358 | 2,230 | 2,064 | 2,158 | 2,030 | 1,678.7 | 1,512.7 | 1,371.2 |
Gross Profit
| 3,618 | 3,104 | 1,727 | 1,615 | 3,195 | 2,894 | 2,205 | 1,787 | 1,559 | 1,396.9 | 1,384.1 | 1,403.2 |
Gross Profit Ratio
| 0.526 | 0.549 | 0.528 | 0.508 | 0.575 | 0.565 | 0.517 | 0.453 | 0.434 | 0.454 | 0.478 | 0.506 |
Reseach & Development Expenses
| -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 197 | 153 | 157 | 171 | 175 | 148 | 124 | 117 | 94 | 82 | 64 | 57.2 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 197 | 153 | 157 | 171 | 175 | 148 | 124 | 117 | 94 | 82 | 64 | 57.2 |
Other Expenses
| -197 | -153 | -157 | -168.9 | -159 | 716 | 1,566 | 964 | -94 | 0 | 0 | 0 |
Operating Expenses
| 197 | 153 | 157 | 171 | 175 | 148 | 124 | 117 | 94 | 82 | 64 | 57.2 |
Operating Income
| 3,421 | 4,021 | 1,178 | -440 | 4,379 | 4,184 | 3,985 | 3,114 | 2,856 | 2,497.7 | 1,695.2 | 1,614.4 |
Operating Income Ratio
| 0.497 | 0.711 | 0.36 | -0.138 | 0.789 | 0.817 | 0.933 | 0.789 | 0.796 | 0.812 | 0.585 | 0.582 |
Total Other Income Expenses Net
| -3,918 | 1,330 | -292 | -1,102 | -885 | -721 | -335 | -479 | -227 | -1,143.9 | -285.9 | -803.8 |
Income Before Tax
| -497 | 5,351 | 886 | -1,542 | 3,494 | 3,463 | 3,650 | 2,635 | 2,629 | 1,353.8 | 1,409.3 | 810.6 |
Income Before Tax Ratio
| -0.072 | 0.946 | 0.271 | -0.485 | 0.629 | 0.676 | 0.855 | 0.668 | 0.733 | 0.44 | 0.487 | 0.292 |
Income Tax Expense
| 83 | 1,147 | 277 | -134 | 794 | 640 | 502 | 421 | 498 | 101.1 | 461.6 | 314.1 |
Net Income
| -585 | 4,217 | 610 | -1,408 | 2,706 | 2,820 | 3,140 | 2,201 | 2,131 | 1,252.7 | 947.7 | 496.5 |
Net Income Ratio
| -0.085 | 0.746 | 0.186 | -0.443 | 0.487 | 0.55 | 0.736 | 0.558 | 0.594 | 0.407 | 0.327 | 0.179 |
EPS
| -3.18 | 22.98 | 3.32 | -7.66 | 15.91 | 16.84 | 19.89 | 14.65 | 14.21 | 8.35 | 6.3 | 3.3 |
EPS Diluted
| -3.18 | 22.98 | 3.32 | -7.66 | 15.91 | 16.84 | 19.89 | 14.65 | 14.21 | 8.35 | 6.3 | 3.3 |
EBITDA
| 3,707 | 4,355 | 1,458 | -202 | 4,574 | 4,347 | 4,155 | 3,261 | 2,993 | 2,607.3 | 1,797.5 | 1,702.5 |
EBITDA Ratio
| 0.539 | 0.77 | 0.445 | -0.064 | 0.824 | 0.848 | 0.973 | 0.827 | 0.834 | 0.848 | 0.621 | 0.614 |